中国妇幼保健

参考文献

[1]Nawrocka J,Starczewski A.Effect of metformin treatment in women with polycystic ovarian syndrome depends on insulin resistance[J].Gynecol Endorinol,2007,23(4):231-237.

[2]杨柳青.多囊卵巢综合征临床分析[J].北方药学,2012,9(1):52.

[3]董丽霞.同型半胱氨酸代谢异常与多囊卵巢综合征相关性研究[D].石家庄:河北医科大学,2005:1-9.

[4]林超,孟安琪.孟安琪教授治疗多囊卵巢综合征的经验总结[J].中国中医药现代远程教育,2011,3(19):77-78.

[5]Franks S,Gharani N,Waterworth D,et al.Genetics of polycystic ovary syndrome[J].Mol Cell Endocrinol,1998,145(1-2):123-128.

[6]Martínez-García M,Gambineri A,Alpa1és M,et al.Common variants in the sex hormone-binding globulin gene(SHBG)and polycystic ovary syndrome(PCOS)in Mediterranean women[J].Hum Repred,2012,27(12):3569-3576.

[7]Erdngan M,Karadeniz M,Berdeli A,et al.The relationship of the interleukin-6-174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystie ovary syndrome patients[J].Int J Immunogenet,2009,36(5):283-288.

[8]代晶芳,李晓林.多囊卵巢综合征易感基因多态性的研究进展[J].山东医药,2013,53(34):98-101.

[9]刘慎霞.多囊卵巢综合征病因学研究进展[J].临床医药文献杂志,2014,1(11):2060-2062.

[10]曹云霞,王玉蓉.多囊卵巢综合征与心理因素的关系[J].中国使用妇科与产科杂志,2007,23(9):675-678.

[11]黄卫娟,刘嘉茵,李利娜.环境因素与多囊卵巢综合征发病的相关性分析[J].中华妇产科杂志,2007,42(5):302-304.

[12]李增一,李玉秀.二甲双胍在多囊卵巢综合征治疗中的作用[J].药物评价,2012,9(25):15.

[13]吴香春.多囊卵巢综合征患者胰岛素抵抗的临床分析[J].中国性科学,2014,23(6):12-13.

[14]Pasquali R,Patton L,Pocognoli P,et al.17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome[J].Clin Endocrinol Metab,2007,92(11):4208-4217.

[15]陈珊,傅正英.多囊卵巢综合征治疗的最新进展[J].临床和实验医学杂志,2010,9(15):1187-1189.

[16]Norman RJ,Noa Kes M,Wu R,et al.Improving,reproductive performance overwight/obese women with effective weight management[J].Hum Reprod Update,2004,10(3):267.

[17]Pasquali R,Gambineri AG,Cavazaa C,et al.Herterogeneity in the responsiveness to long-term lifestyle intervention and predict-ability in ohese women with polycystic ovary syndrome[J].Eur JEndocrinol,2011,164(1):53-60.

[18]刘新军,王皓.三联法综合治疗多囊卵巢综合征的疗效观察[J].中国临床研究,2013,26(4):18-19.

[19]宁光.内分泌内科学[M].第2版,北京:人民卫生出版社,2014:249-255.

[20]Cagnacci A,Paoletti AM,Renzi A.Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contrceptives containing cyproterone acetate or desogestre[J].Clin Endocrinol Metab,2003,88(8):3621-3625.

[21]郭晓慧.抗胰岛素抵抗药物治疗多囊卵巢综合征[J].中国实用医药,2010,5(20):63-64.

[22]张娜,郭丽娜,吕翠婷.达英-35联合不同胰岛素增敏剂对P-COS伴IR患者的临床疗效比较[J].现代妇产科进展,2008,17(6):440-443.

[23]王爱艳.改善胰岛素抵抗药物治疗多囊卵巢综合征的研究综述[J].医院前沿,2014,4(25):107-108.

[24]刘艳红,王霞,王爱华.二甲双胍联合达英-35在多囊卵巢综合征促排卵疗效的影响[J].中国妇幼保健,2008,23(9):1266-1268.

[25]De Leo VDE,Marca ALA,Petiaglia F.Insulin-lowering agents in the management of polycystic ovary syndrome[J].Endocrine Rev,2003,24(5):633-667.

[26]Veldhuis JD,Zhang G,Garmey JC.Troglitazone,an insulin sensitizing thiazolidinedione,respresses combined stimulation by LH and insulin of de novo and rogen biosynthesis by thecal cell in vitro[J].J Clin Endocrinol Metab,2002,87(3):1129-1133.

[27]孙玉菡,吴红.二甲双胍和罗格列酮治疗多囊卵巢综合征的临床疗效观察[J].重庆医科大学学报,2010,35(2):267-270.

[28]Zomoza A,Rovira J,Laparte C.Surscal options in the treatment of polycystic ovary syndrome[J].Rev Med Univ Navarra,1997,41(4):230-236.

[29]Rausch ME,Legro RS,Barnhart HX,et al.Reproductive Medicine Network.Predictors of pregnancy in women with polycystic ovary syndrome[J].Clin Endocrinol Metab,2009,94(9):3458-3466.

[30]邱云云,汪志红.减肥手术对多囊卵巢综合征疗效的研究进展[J].临床医学,2015,28(19):349.

[31]史亮亮,付正英.多囊卵巢综合征的中医药研究进展[J].光明中医,2013,28(6):1300-1301.

[32]任晓旭,吴效科.针刺治疗多囊卵巢综合征的作用机制及临床研究进展[J].云南中医药杂志,2014,35(11):61-72.